Anticancer Activity of Solvent Extracts of Hexogonia glabra against Cervical Cancer Cell Lines.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Jul 2020
Historique:
received: 28 12 2019
entrez: 27 7 2020
pubmed: 28 7 2020
medline: 7 4 2021
Statut: epublish

Résumé

In this study, we aimed to harness some solvent extracts of one wild mushroom Hexagonia glabra and test their anti-cancer activity against cervical human cell lines, namelyHeLa, SiHa, and CaSki. It includes cell morphological study by microscope, nuclear morphology by DAPI staining under fluorescence microscopy, apoptosis assay by fluorescence technique, anti-proliferation by MTT assay and expression of apoptotic and anti-apoptotic genes by Western blotting and cell cycle analysis was done. The selected cervical cancer cells were treated separately with 150 µg/mL of three extracts, namely of ethanolic (EE), ethyl acetate (EAE), and water extract (WE) and exhibited features like round, shrink and dead. All extracts caused apoptosis in cell lines and EE had the highest effect in this regard. The percentages of apoptotic cells in HeLa, SiHa and CaSki, at the same concentration of EE were 79.23, 75.42, and 76.36% respectively. Cytotoxicity assay showed that all three extracts (50 - 250 μg/mL) were potent for inhibition of cell growth of three cell lines and again EE had the highest effect. The percentages of cell growth inhibition in HeLa, SiHa, and CaSki cells treated with EE at 24 h at 50 µg/mL were 45.79±4.11, 41.66±4.03, and 36.72±2.67, while they were 74.23±7.45, 62.31±5.97, and 54.23±5.04 at 150 µg/mL concentration. At 250 µg/mL concentration, the percentages of cell growth inhibition were 94.25 ±8.11, 90.02 ±8.67, and 85.43±6.21, respectively. The expression of apoptotic gene (Caspase 3, 9) and tumor guard gene (p53), as their proteins in Western blotting increased . However, anti-apoptotic BcL2 gene of all cell lines was decreased following treatment with extracts. In addition, the cell cycle analysis (CaSki cell) showed that treatment (EE) arrested at G2/M check point cell cycle. All extracts of this mushroom were active in arresting growth of three cell lines and EE had the highest effect, indicating that this mushroom can be a valuable source of anticancer agents.

Identifiants

pubmed: 32711423
doi: 10.31557/APJCP.2020.21.7.1977
pmc: PMC7573405
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
Plant Extracts 0
Solvents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1977-1986

Références

Oncol Rep. 2006 Dec;16(6):1349-55
pubmed: 17089060
Life Sci. 2003 Nov 7;73(25):3225-34
pubmed: 14561527
Cancer Lett. 2006 Nov 28;244(1):61-70
pubmed: 16413114
J Nutr Biochem. 2012 Aug;23(8):900-7
pubmed: 21840189
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74
pubmed: 12436306
Cancer Lett. 2004 Dec 8;216(1):9-20
pubmed: 15500944
Mol Biol Rep. 2008 Jun;35(2):107-17
pubmed: 17431821
Cancer Lett. 2005 Mar 18;220(1):21-8
pubmed: 15737684
Fitoterapia. 2010 Dec;81(8):1067-72
pubmed: 20603196
Int J Med Mushrooms. 2011;13(1):19-25
pubmed: 22135900
Int J Womens Health. 2015 Apr 16;7:405-14
pubmed: 25931830
Int Immunopharmacol. 2007 Jun;7(6):701-24
pubmed: 17466905
Biotechnol Adv. 2011 Nov-Dec;29(6):667-74
pubmed: 21605654
Nutr Cancer. 2004;49(2):209-16
pubmed: 15489214
Int J Oncol. 2006 Sep;29(3):695-703
pubmed: 16865287
J Ethnopharmacol. 2014 Mar 14;152(2):372-6
pubmed: 24491644
J Biosci Bioeng. 2009 Jan;107(1):42-8
pubmed: 19147108
Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12
pubmed: 18037277
J Nat Prod. 2004 May;67(5):823-8
pubmed: 15165144
Int J Immunopharmacol. 1996 May;18(5):295-303
pubmed: 8933208
Science. 2002 Jul 19;297(5580):415-6
pubmed: 12130788
Med Monatsschr Pharm. 2010 Feb;33(2):40-8
pubmed: 20184262
J Ethnopharmacol. 2011 Jan 27;133(2):460-6
pubmed: 20951789
Life Sci. 2003 Apr 11;72(21):2381-90
pubmed: 12639703
Cancer Immunol Immunother. 1993;36(2):123-6
pubmed: 8425209
Appl Microbiol Biotechnol. 2005 Jun;67(4):453-68
pubmed: 15726350
J Biochem Biophys Methods. 1996 May 14;32(2):85-96
pubmed: 8796481
Immunity. 2003 Sep;19(3):311-5
pubmed: 14499107
J Ethnopharmacol. 2010 Aug 19;131(1):56-62
pubmed: 20554007
J Ethnopharmacol. 2009 Jan 21;121(2):221-8
pubmed: 19041933
Am J Bot. 2011 Mar;98(3):426-38
pubmed: 21613136
Phytochemistry. 2011 Jun;72(9):923-8
pubmed: 21477823
Toxicol In Vitro. 2009 Apr;23(3):418-24
pubmed: 19344682
Immunopharmacol Immunotoxicol. 1997 May;19(2):175-83
pubmed: 9130004
J Nat Prod. 2009 Aug;72(8):1405-9
pubmed: 19624146
Arch Biochem Biophys. 2009 Oct 15;490(2):103-9
pubmed: 19733546
J Ethnopharmacol. 2008 Jan 4;115(1):50-6
pubmed: 17936529
Antibiot Chemother (Northfield). 1957 Jan;7(1):1-4
pubmed: 24544235
Int J Oncol. 2010 Dec;37(6):1529-36
pubmed: 21042722
Appl Microbiol Biotechnol. 2011 Mar;89(5):1323-32
pubmed: 21190105

Auteurs

Swapan Kumar Ghosh (SK)

Molecular Mycopathology Lab, Cancer Research Unit, PG Department of Botany, Ramakrishna Mission Vivekananda Centenary College (Autonomous), Rahara, Kolkata 700118, India.

Tapojyoti Sanyal (T)

Molecular Mycopathology Lab, Cancer Research Unit, PG Department of Botany, Ramakrishna Mission Vivekananda Centenary College (Autonomous), Rahara, Kolkata 700118, India.

Tanmay Bera (T)

Molecular Mycopathology Lab, Cancer Research Unit, PG Department of Botany, Ramakrishna Mission Vivekananda Centenary College (Autonomous), Rahara, Kolkata 700118, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH